COTI-2, a novel thiosemicarbazone derivative, exhibits antitumor activity in HNSCC through p53-dependent and -independent mechanisms
Lindemann, Antje, Patel, Ameeta A, Tang, Lin, Liu, Zhiyi, Wang, Li, Silver, Natalie L, Tanaka, Noriaki, Rao, Xiayu, Takahashi, Hideaki, Maduka, Nakachi K, Zhao, Mei, Chen, Tseng-Cheng, Liu, WeiWei, GaJournal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-19-0096
Date:
July, 2019
File:
PDF, 1.67 MB
2019
File converter
More search results
More benefits 
